Rapport Therapeutics, Inc. Common StockRAPPNASDAQ

Revenue (LTM)

Net Income (LTM)

$-111M

-42.4% YoY

Free Cash Flow

$-88M

Revenue CAGR (5Y)

—

—Marginsstable

FCF($0.1B)

Unprofitable

Metric	Dec 22	Dec 23	Dec 24	Dec 25
Revenue	0	0	0	0
Gross Profit	-0	-0↓646.7%	-1↓649.1%	-1↓21.2%
Operating Income	-10	-36↓249.0%	-83↓129.6%	-125↓50.6%
Net Income	-11	-35↓226.6%	-78↓125.1%	-111↓42.4%
EBITDA	-10	-35↓234.9%	-77↓123.5%	-124↓60.2%
EPS Diluted	-0.05	-0.19↓258.5%	-0.38↓100.0%	-2.86↓652.6%

Metric	Dec 22	Dec 23	Dec 24	Dec 25
Cash & Equivalents	31	70↑125.2%	57↓19.0%	53↓7.3%
Total Current Assets	31	151↑382.5%	310↑105.3%	499↑60.9%
Total Assets	32	155↑391.8%	315↑102.6%	512↑62.7%
Total Current Liabilities	2	9↑429.3%	9↓0.4%	19↑117.3%
Total Liabilities	12	181↑1396.6%	10↓94.7%	28↑192.2%
Total Equity	20	-26↓231.4%	305↑1291.5%	485↑58.7%
Total Debt	10	2↓79.4%	1↓31.2%	11↑678.0%
Net Debt	-21	-68↓228.2%	-55↑18.7%	-41↑25.6%

Metric	Dec 22	Dec 23	Dec 24	Dec 25
Operating Cash Flow	-3	-27↓738.4%	-65↓138.5%	-87↓34.9%
Capital Expenditure	-0	-2↓476.1%	-2↓47.0%	-1↑74.4%
Free Cash Flow	-4	-29↓717.3%	-67↓133.3%	-88↓31.0%
Stock-Based Comp	1	4↑478.0%	10↑190.4%	0
Net Change in Cash	31	39↑25.5%	-13↓134.1%	-4↑68.8%

Values in millions except EPS · Ratios shown as percentages · Click any metric to drill down

Explore More

Filter and sort all 500 stocks

Today's biggest gainers and losers

Visual sector performance